|
1. Head
Office:
3/5 Sapara Street,
Off Oba Akran Avenue,
Ikeja
Industrial Estate,
P. M.
B. 21049, Ikeja, Lagos.
Tel:
234-01-4968130 - 6, 8980079, 8980080, 4967067, 4978199,
4960554,
4962951
Fax:
234-01-4962832. Telex: 26258 MANDB NG.
E-mail:
info@may-baker.com;
Website:
www.may-baker.com
2. Nature of
Business:
Manufacturing
and Distribution of Pharmaceutical Products, Diagnostics Equipment,
Reagents, Consumer Products and Human Vaccines.
3. Date of
Incorporation:
4th
September, 1944.
4. Date
Listed on The Exchange:
10th November, 1994.
5. NSE
Classification:
Healthcare
6. Board of
Directors:
Lt.
Gen. T. Y. Danjuma (Rtd.) - (Chairman)
Mr.
J. I. Odumodu - (MD/CEO)
Mr.
N. N. Okafor
Mr.
T. U. Udoh
Mrs.
O. F. Oshai
Prof.
Deji Femi-Pearse
Lady
E. U. Ekaette
Mr.
David Dankaro
Mrs.
V. I. P. Alozie
7. Company
Secretary:
Marina
Nominees Limited
233 Ikorodu Road,
Ilupeju,
Lagos.
|
8. Auditors:
Akintola
Williams Deloitte
(Chartered
Accountants)
235 Ikorodu Road,
Ilupeju,
Lagos.
9. Company
Registrars:
Afribank
Registrars Limited
2A
Gbagada Expressway
Anthony,
Lagos.
10. Subsidiaries/Associates:
Bio-vaccines
Nigeria Limited
Aurobindo
Pharma Limited
Sanwa
Inter-Foods Limited, Thailand
Aventis
Phama International
11. End of
Accounting Year
31st
December.
12. Number
of Employees
327
13. Capital
Structure
i. Authorised: N500,000,000.00
ii. Paid-Up N350,000,000.00
14. Analysis
of Shareholding
Nigerian
Citizens & Associations 100%
|
|
FIVE-YEAR FINANCIAL SUMMARY
ASSETS
EMPLOYED 2007 2006 2005 2004 2003
N‘000 N‘000 N‘000 N‘000 N‘000
Fixed assets 1,026,590 940,643 387,196 302,617 318,919
Capital work in progress 57,522 - 185,825 - -
Leased assets 367,962 384,322 3,812 39,539 42,164
Investment in subsidiary 245,325 245,325 - - -
Intangible assets 80,633 93,864 67,296 67,296 -
Net current assets 1,094,240 1,313,495 809,452 508,954 400,804
--------- --------- --------- --------- --------
2,872,272 2,977,649 1,453,581 918,406 761,887
Deferred taxation (159,771) (67,719) (83,034) (76,179) (67,215)
Term Loans - (42,330) (492,559) (74,665) -
Lease payable (21,562) (183,618) - (2,138) (10,919)
Gratuity (75,275) (66,636) (61,084) (50,278) (44,356)
--------- --------- --------- --------- ---------
2,615,664 2,617,346 816,905 715,146 639,397
===== ===== ===== ===== ======
CAPITAL AND RESERVES:
Share capital 350,000 350,000 108,590 90,492 90,492
Share premium 1,641,394 1,641,394 217,820 217,820 217,820
Bonus issue reserve - - 10,859 18,098 -
General Reserve 624,270 625,952 479,636 388,736 331,085
--------- --------- --------- --------- --------
2,615,664 2,617,346 816,905 715,146 639,397
===== ===== ===== ===== =====
TURNOVER AND PROFITS:
Turnover 3,859,749 2,253,389 1,996,974 1,900,865 1,780,448
===== ===== ===== ===== =====
Profit before taxation 398,078 266,191 154,621 126,158 134,489
Taxation (189,760) (54,721) (52,862) (35,019) (55,322)
--------- --------- --------- --------- --------
Profit after tax 208,318 211,470 101,759 91,139 79,167
Transfer to reserve for bonus issue - - (10,859) (18,098) -
--------- --------- --------- --------- --------
208,318 211,470 90,900 73,041 79,167
===== ===== ===== ===== =====
PER SHARE DATA (KOBO))
Earnings
- Basic 30 30 47 50 44
- Diluted - - 15 10 11
Dividend 40 30 30 - 25
Dividend cover
(times) - 1.00 1.60 - 1.5
Net Assets 373.67 373.91 376.14 395.15 353.29
===== ===== ===== ===== =====
NOTE:
Earnings per share are based on profit after tax
and the number of issued and fully paid ordinary shares at the end of each
financial year. Net assets per share are based on net assets and the number
of issued and fully paid ordinary shares at the end of each financial year.
|
